Cargando…

Ibrutinib has some activity in Richter's syndrome

Detalles Bibliográficos
Autores principales:	Giri, S, Hahn, A, Yaghmour, G, Martin, M G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404220/ https://www.ncbi.nlm.nih.gov/pubmed/25635530 http://dx.doi.org/10.1038/bcj.2014.98

Ejemplares similares

Ibrutinib and rituximab induced rapid response in refractory Richter syndrome
por: Lamar, Zanetta, et al.
Publicado: (2015)

An experience with ibrutinib monotherapy for Richter’s syndrome isolated in the central nervous system
por: Nato, Yuma, et al.
Publicado: (2022)

Richter Syndrome
por: Condoluci, Adalgisa, et al.
Publicado: (2021)

Allogeneic hematopoietic cell transplantation outcomes in patients with Richter’s transformation
por: Kim, Haesook T., et al.
Publicado: (2021)

Ibrutinib-Induced Skin Rash
por: Kirar, Sudhir, et al.
Publicado: (2021)

Hodgkin's variant of Richter transformation during ibrutinib therapy: A case report and review of the literature
por: Afonso, Carolina, et al.
Publicado: (2022)

Periorbital Richter Syndrome
por: Gorman, Mark, et al.
Publicado: (2015)

Novel Approaches for the Treatment of Patients with Richter’s Syndrome
por: Iannello, Andrea, et al.
Publicado: (2022)

Pirtobrutinib results in reversible platelet dysfunction compared to ibrutinib and acalabrutinib
por: Bye, Alexander P., et al.
Publicado: (2022)

Rationale for the combination of venetoclax and ibrutinib in T-prolymphocytic leukemia
por: Kornauth, Christoph, et al.
Publicado: (2021)

Ibrutinib-associated alveolar hemorrhage and spontaneous hemothorax
por: Tombul, Ismail, et al.
Publicado: (2022)

Ibrutinib-Induced Pancreatitis in Patients with Waldenstrom Macroglobulinemia
por: Büyükkurt, Nurhilal, et al.
Publicado: (2023)

Ibrutinib-Induced Cardiac Tamponade in Chronic Lymphocytic Leukemia
por: Kidoguchi, Keisuke, et al.
Publicado: (2021)

The role of (18)F-FDG-PET in detecting Richter transformation of chronic lymphocytic leukemia in patients receiving therapy with a B-cell receptor inhibitor
por: Wang, Yucai, et al.
Publicado: (2020)

PB1861: ACALABRUTINIB IN THE TREATMENT OF RICHTER SYNDROME
por: Byalik, T., et al.
Publicado: (2022)

Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation
por: Hodkinson, Brendan P., et al.
Publicado: (2020)

A phase 2 study of nivolumab combined with ibrutinib in patients with diffuse large B-cell Richter transformation of CLL
por: Jain, Nitin, et al.
Publicado: (2022)

Pembrolizumab in relapsed or refractory Richter syndrome
por: Armand, Philippe, et al.
Publicado: (2020)

Nurse-like cells mediate ibrutinib resistance in chronic lymphocytic leukemia patients
por: Boissard, F, et al.
Publicado: (2015)

Richter's syndrome: a novel presentation.
por: Smyth, E. F., et al.
Publicado: (2003)

Preclinical evaluation of the Hsp90 inhibitor SNX-5422 in ibrutinib resistant CLL
por: Chen, Timothy L., et al.
Publicado: (2021)

Successful Treatment of Richter Transformation with Ibrutinib in a Patient with Chronic Lymphocytic Leukemia following Allogeneic Hematopoietic Stem Cell Transplant
por: Master, Samip, et al.
Publicado: (2017)

Midostaurin-Related Interstitial Lung Injury in FLT3(+) Acute Myeloid Leukemia Post-Allogeneic Transplant
por: Vaidya, Poorva, et al.
Publicado: (2019)

Extranodal Richter's syndrome of the urinary bladder
por: Carrión-Valencia, Almudena, et al.
Publicado: (2018)

Current trends in the management of Richter's syndrome
por: Allan, John N, et al.
Publicado: (2019)

Immunochemotherapy for Richter syndrome: current insights
por: Puła, Bartosz, et al.
Publicado: (2019)

Concomitant Presence of CD5-Positive Diffuse Large B-Cell Lymphoma and Monoclonal B Cells with the “CLL Immunophenotype” - Is It Richter’s Transformation?
por: Langer, Sabina, et al.
Publicado: (2017)

Sviatoslav Richter.
por: Beethoven, Ludwig van, 1770-1827
Publicado: (1998)

Sviatoslav Richter
Publicado: (1998)

Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study
por: Montillo, M, et al.
Publicado: (2017)

Predictors of atrial fibrillation in ibrutinib-treated CLL patients: a prospective study
por: Reda, Gianluigi, et al.
Publicado: (2018)

Successful Management of Ibrutinib-Induced Thrombocytopenia with Eltrombopag in a Patient with Waldenström Macroglobulinemia
por: Erçalışkan, Abdülkadir, et al.
Publicado: (2022)

Obinutuzumab in Allogeneic Transplantation for CLL and Richter’s Transformation in the Age of Targeted Therapies
por: Pflug, Natali, et al.
Publicado: (2021)

PB1881: IBRUTINIB REDUCES THE RISK OF RICHTER’S TRANSFORMATION IN PREVIOUSLY TREATED CLL PATIENTS: A POPULATION-BASED STUDY IN BRITISH COLUMBIA
por: Ramadan, R., et al.
Publicado: (2022)

The involvement of microRNA in the pathogenesis of Richter syndrome
por: Van Roosbroeck, Katrien, et al.
Publicado: (2019)

Prof. P. F. Richter on Some New Ideas on Diseases of Metabolism
Publicado: (1908)

Anti-CD37 α-amanitin–conjugated antibodies as potential therapeutic weapons for Richter syndrome
por: Vaisitti, Tiziana, et al.
Publicado: (2022)

Successful Treatment of Chronic Lymphocytic Leukemia Multifocal Central Nervous System Involvement with Ibrutinib
por: Christoforidou, Anna, et al.
Publicado: (2018)

Severe Lymphocytosis in a Case of Diffuse Large B-Cell Lymphoma Treated by Ibrutinib
por: Paydaş, Semra, et al.
Publicado: (2021)

Ibrutinib-Associated Multifocal Paronychia with Periungual Pyogenic Granulomas Involving Concomitant Finger and Toe Nails
por: Kaur, Lovleen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5e235o7cg3dhcel2urhl4ol9mt